Literature DB >> 10416062

Liquid chromatographic bioanalytical determination of ropivacaine, bupivacaine and major metabolites.

T Arvidsson1, Y Askemark, M M Halldin.   

Abstract

Bioanalytical methods for the determination of ropivacaine, bupivacaine and their major metabolites in urine and blood plasma are presented. Ropivacaine is a new local anaesthetic drug mainly used for surgery and for postoperative pain relief. The samples are hydrolysed and cleaned using solid-phase extraction and analysed using ion-pair reversed-phase liquid chromatography with gradient elution. The analytes are detected using UV at 210 nm. The methods are highly selective and the limits of quantification were 1 microM in urine and 0.1 microM in plasma, respectively. The between-day variance was generally below 3% (RSD).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10416062     DOI: 10.1002/(SICI)1099-0801(199906)13:4<286::AID-BMC862>3.0.CO;2-M

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  3 in total

1.  Determination of bupivacaine and metabolites in rat urine using capillary electrophoresis with mass spectrometric detection.

Authors:  Ryan M Krisko; Mark A Schieferecke; Todd D Williams; Craig E Lunte
Journal:  Electrophoresis       Date:  2003-07       Impact factor: 3.535

2.  Application of a column selection system and DryLab software for high-performance liquid chromatography method development.

Authors:  Ryan M Krisko; Kieran McLaughlin; Michael J Koenigbauer; Craig E Lunte
Journal:  J Chromatogr A       Date:  2006-05-18       Impact factor: 4.759

3.  Rectal ropivacaine is absorbed proportionally to the dose, with low intraindividual variability.

Authors:  Eva Arlander; Jan Sjövall; Jörgen Sörstad; Carina Norsten-Höög; Lars L Gustafsson
Journal:  Br J Clin Pharmacol       Date:  2003-01       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.